Skip Nav Destination
1-2 of 2
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Hematology Am Soc Hematol Educ Program (2022) 2022 (1): 481–490.
Evidence-Based Minireview: Should caplacizumab be used routinely in unselected patients with immune thrombotic thrombocytopenic purpura?
Hematology Am Soc Hematol Educ Program (2022) 2022 (1): 491–494.